AI-generated summary
In this randomized split-face study of 30 patients with melasma, the authors compared low-fluence picosecond 1064 nm laser with microlens arrays against laser alone on the opposite side of the face. They report significant MASI score reductions at all follow-up times, fewer recurrences on the microlens side at six months, and no significant adverse events.
- Participants
- 30
- Who or what was studied
- Patients with melasma
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract does not report a formal statistical comparison of MASI or P-GAIS outcomes between sides, and the sample size is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.